1
|
Buch J, Sonoda L, Cannon J. Unexpected vision performance with photochromic contact lenses in normal and low light conditions: An analysis of two randomized trials. J Optom 2023; 16:135-142. [PMID: 35953430 PMCID: PMC10104794 DOI: 10.1016/j.optom.2022.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/02/2022] [Revised: 04/04/2022] [Accepted: 06/16/2022] [Indexed: 06/15/2023]
Abstract
PURPOSE Evaluate the performance of a photochromic contact lens in various lighting conditions throughout the day, including those indoor and outdoor environments where the photochromic contact lens is in a less active or inactive state. METHODS Data from two clinical trials of a photochromic contact lens were analyzed to evaluate its performance in various light environments. Both studies involved a photochromic test lens (ACUVUE® OASYS with Transitions™ Light Intelligent Technology™) and a similar non-photochromic control lens (ACUVUE® OASYS 2-week with HYDRACLEAR® PLUS). The studies were both multi-visit, multi-site, 2-treatment by 3-period randomized crossover (i.e., Test/Control/Control or Control/Test/Test) dispensing studies, with follow-up visits after each 2-week dispensing period. RESULTS A total of 250 subjects were dispensed lenses across both studies, of which 237 total subjects completed. In situations where exposure to an activating light source is common (e.g., outdoors), the Test lens was preferred nearly 6:1 over the control lens. In situations where exposure to an activating light source is less common - indoors, driving at night, using digital devices -, the Test lens was still preferred over the control lens by margins of 4:1, nearly 4:1, and over 3:1 respectively. The Test lens was superior with respect to quality of vision, ability to see comfortably, clarity of vision, reduction of squinting while using computers and reduction of bright light while driving at night. CONCLUSION The photochromic test contact lens was rated superior to a non-photochromic control lens in environmental situations where the lens is in a less active or inactive state.
Collapse
Affiliation(s)
- John Buch
- Johnson and Johnson Vision Care Inc., 7500 Centurion Parkway, Jacksonville, FL 32256, Unites States.
| | - Leilani Sonoda
- Johnson and Johnson Vision Care Inc., 7500 Centurion Parkway, Jacksonville, FL 32256, Unites States.
| | - Jessica Cannon
- Johnson and Johnson Vision Care Inc., 7500 Centurion Parkway, Jacksonville, FL 32256, Unites States.
| |
Collapse
|
2
|
Gronert K, Modi A, Asfaha K, Chen S, Dow E, Joslin S, Chemaly M, Fadli Z, Sonoda L, Liang B. Silicone hydrogel contact lenses retain and document ocular surface lipid mediator profiles. Clin Exp Optom 2022:1-9. [PMID: 35658852 DOI: 10.1080/08164622.2022.2083945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Abstract
CLINICAL RELEVANCE A leading reason for patients to abandon their contact lenses is discomfort. Mechanisms and biomarkers for lens discomfort remain to be elucidated. BACKGROUND Physical stress and tear film interaction are likely factors for lens discomfort. Lipid mediators are generated from polyunsaturated fatty acids. They regulate ocular surface physiology and pathophysiology, are constituents of human tears and may interact with contact lenses. This study set out to determine if hydrogel lenses and silicone hydrogel lenses interact with tear film polyunsaturated fatty acids and polyunsaturated fatty acids-derived mediators. METHODS In vitro incubations, rat experiments and analysis of worn human lenses assessed polyunsaturated fatty acids and lipid mediator interactions with lenses. Silicone hydrogel and hydrogel lenses were incubated with lipid mediators and polyunsaturated fatty acids up to 24 hours. Rats were fitted with custom silicone hydrogel lenses and basal tears collected. Silicone hydrogel lenses worn for 2 weeks were obtained from 57 human subjects. Tear and lens lipidomes were quantified by mass spectrometry. RESULTS Silicone hydrogel lenses retained polyunsaturated fatty acids and lipid mediators within 15 minutes in vitro. Lenses contained 90% of total polyunsaturated fatty acids and 83-89% of total monohydroxy fatty acids by 12 hours. Retention correlated with polarity of lipid mediators and lipophilic properties of silicone hydrogel lenses. Polyunsaturated fatty acids and lipid mediators such as lipoxygenase- and cyclooxygenase-derived eicosanoids were present in tears and worn lenses from rats. Worn silicone hydrogel lenses from human subjects established robust and lens-type specific lipidomes with high levels of polyunsaturated fatty acids, lipoxygenase-pathway markers and subject-specific differences in lipoxin A4 and leukotriene B4. CONCLUSION Worn silicone hydrogel lenses rapidly retain and accumulate tear polyunsaturated fatty acids and lipid mediators. Marked subject and lens type differences in the lipidome may document changes in ocular surface physiology, cell activation or infection that are associated with lens wear. If contact lens discomfort and adverse events induce specific tear and lens fatty acid and lipid mediator profiles warrants further studies.
Collapse
Affiliation(s)
- Karsten Gronert
- Vision Science Program, Herbert Wertheim School of Optometry & Vision Science, Infectious Disease and Immunity Program, University of California Berkeley, Berkeley, CA, USA
| | - Arnav Modi
- Vision Science Program, Herbert Wertheim School of Optometry & Vision Science, Infectious Disease and Immunity Program, University of California Berkeley, Berkeley, CA, USA
| | - Kaleb Asfaha
- Vision Science Program, Herbert Wertheim School of Optometry & Vision Science, Infectious Disease and Immunity Program, University of California Berkeley, Berkeley, CA, USA
| | - Sharon Chen
- Vision Science Program, Herbert Wertheim School of Optometry & Vision Science, Infectious Disease and Immunity Program, University of California Berkeley, Berkeley, CA, USA
| | - Elizabeth Dow
- Advance Science and Technology, Johnson & Johnson Vision Care, Jacksonville, FL, USA
| | - Scott Joslin
- Advance Science and Technology, Johnson & Johnson Vision Care, Jacksonville, FL, USA
| | - Mike Chemaly
- Advance Science and Technology, Johnson & Johnson Vision Care, Jacksonville, FL, USA
| | - Zohra Fadli
- Advance Science and Technology, Johnson & Johnson Vision Care, Jacksonville, FL, USA
| | - Leilani Sonoda
- Advance Science and Technology, Johnson & Johnson Vision Care, Jacksonville, FL, USA
| | - Bailin Liang
- Advance Science and Technology, Johnson & Johnson Vision Care, Jacksonville, FL, USA
| |
Collapse
|
3
|
Gronert K, Modi A, Asfaha K, Chen S, Dow E, Joslin S, Chemaly M, Fadli Z, Sonoda L, Liang B. Silicone Hydrogel Contact Lenses Retain and Document Ocular Surface Lipid Mediator Profiles. Cont Lens Anterior Eye 2022. [DOI: 10.1016/j.clae.2022.101673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
4
|
Hammond BR, Buch J, Sonoda L, Renzi-Hammond L. The Effects of a Senofilcon A Contact Lens With and Without a Photochromic Additive on Positive Dysphotopsia Across Age. Eye Contact Lens 2021; 47:265-270. [PMID: 33878065 PMCID: PMC8059875 DOI: 10.1097/icl.0000000000000731] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/11/2020] [Indexed: 11/26/2022]
Abstract
OBJECTIVE The visual effects of wearing a photochromic contact lens (test) were directly compared with a nonphotochromic contact lens (control). Positive dysphotopsia (halos, starbursts) and intraocular scatter (behaviorally determined) were assessed. Both younger and middle-aged subjects were evaluated to examine the influence of age. METHODS Fifty-four subjects (18-62 years) were tested using a contralateral design. Subjects were fit with a photochromic contact lens on one eye and a nonphotochromic contact lens on the other eye, randomly assigned. Testing occurred with and without photochromic activation (darkened) by use of a violet activator (365 nm, half-bandwidth 20 nm). The extent of dysphotopsia (halos and spokes) was measured using an aperture (∼4 mm) that created a bright point source of light 45 inches from the plane of the eye. Between the point source and subject, a centering precision caliper was used to measure lateral spread. Two-point thresholds were determined by measuring the minimum distance between two points of broadband xenon light. RESULTS The photochromic contact lens produced smaller halo diameters than the control contact lens, both activated (41% on average) and inactivated (21% on average), and age strata was a significant factor (P<0.001) with the older group showing a greater reduction. The photochromic contact lens produced smaller starburst diameters than the control contact lens, both activated (37% on average) and inactivated (23% on average), and age strata was a significant factor (P=0.001) with the older group showing a greater reduction. The two-point thresholds were reduced (25% activated, 9% inactivated) on average but the age effect was not significant (P<0.10). CONCLUSIONS The senofilcon A lens with photochromic additive reduced the extent of positive dysphotopsia compared with the same lens without the additive, regardless whether the lens was activated or not. The visual benefit was greatest with the older subjects.
Collapse
Affiliation(s)
- Billy R Hammond
- Department of Psychology (B.R.H.), Vision Sciences Laboratory, Behavioral and Brain Sciences Program, The University of Georgia, Athens, GA; Johnson and Johnson Vision Care, Inc (L.S.), Jacksonville, FL; and Department of Health Promotion and Behavior (L.R.-H.), Human Biofactors Laboratory, Institute of Gerontology, College of Public Health, The University of Georgia, Athens, GA
| | | | | | | |
Collapse
|
5
|
Ismayilova G, Sonoda L, Fels M, Rizzi R, Oczak M, Viazzi S, Vranken E, Hartung J, Berckmans D, Guarino M. Acoustic-reward learning as a method to reduce the incidence of aggressive and abnormal behaviours among newly mixed piglets. Anim Prod Sci 2014. [DOI: 10.1071/an13202] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The aim of the study was to test whether aggressive actions among piglets could be redirected by an automatically generated sound signal followed by a sweet food reward. Per round, four litters of 25-day-old piglets (BHZP breed) were trained 5 times per day over 8 days to expect a sweet feed reward from a dog feeder after hearing a specific sound. In total 144 piglets in 14 entire litters were trained in five trials. At the end of the training 71% of the piglets were around the feeder 5 s after the feeder sound. After the training period, the piglets were weaned and mixed in two pens, 12 piglets per pen. During 2 days (3 h/day) after mixing two observers (one per pen) hidden behind a wooden wall activated the feeder when aggressive or abnormal behaviour started. A total of 616 aggressive events and 31 incidences of abnormal behaviour (ear biting) were used for the analysis. The logistic regression showed that the type of behaviour had a significant effect on the piglets’ response to the feeder sound (P < 0.001). The results showed the possibility of interruption of the aggressive behaviours such as head thrust [odds ratio (OR) = 0.43], jump on other (OR = 0.56) or attack with bite (OR = 0.61). Ear biting was very unlikely to continue (OR = 0.55). The risk of continuing elevated aggression level behaviours was doubled in the event of chasing (OR = 2.16) and the risk that fight would continue after the feeder sound was released was 7 times higher (OR = 7.89). Categorical analysis showed a significant effect (<0.001) of the time intervals t ≤ 1 s and 1 s < t ≤ 3 s on interruption of aggression by the feeder sound release. The piglets’ response to the feeder sound differed significantly between the experimental days (P < 0.001). On the second day of mixing, the feeder sound interrupted 74.9% of aggressive events, compared with 33.7% on the first day. The results suggest that acoustic-reward treatment can distract pigs from performing certain aggressive behaviours and ear biting in piglets when properly applied in time.
Collapse
|
6
|
Woolf DK, Beresford M, Li SP, Sanghera B, Wong WL, Amin V, Ah-See ML, Miles D, Sonoda L, Detre S, Dowsett M, Makris A. Abstract P4-01-07: Evaluation of FLT PET-CT as an imaging biomarker of proliferation in primary breast cancer. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p4-01-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
[18F]flurothymidine (FLT) is proposed as an positron emission tomography (PET) imaging biomarker of proliferation for breast cancer. The aim of this prospective study was to assess the feasibility of FLT PET-CT as a technique for predicting response to neoadjuvant chemotherapy (NAC) in operable breast cancer and to compare baseline FLT to Ki-67.
Methods
20 patients with primary breast cancer were recruited into this study and 19 received NAC with FEC (n = 6) or FEC-T (n = 13). A baseline FLT PET-CT scan was performed and repeated before the second cycle of chemotherapy. Expression of Ki-67 in the diagnostic biopsy was quantified after being stained by Dako Ki67 MIB-1 antibody and% positive cells scored. From the FLT PET-CT scans standardized uptake value maximum (SUVmax) were calculated.
Results
All 20 patients completed the baseline scan and 17 completed the second scan. Baseline Ki-67 results were available for 19 patients. Median age was 52 years (range 32 to 67), 12 patients were ER/ PR +ve, 6 Her-2 +ve and 6 triple negative.
Mean baseline SUVmax was 7.3 (range 2.92 to 13.87) and 4.62 (range 1.79 to 14.15) post 1 cycle of NAC (range 7 to 14 days), representing a drop of 2.68 (36.3%). Mean baseline Ki-67 was 32.23 (range 2.3 to 68.4). Pearsons correlation showed a significant correlation between pre-chemotherapy Ki-67 and SUVmax of 0.604 (p = 0.006).
7 out of 17 (41%) patients achieved near pCR or pCR (pathological responders) after NAC and all of these had a reduction in SUVmax with a mean percentage value of –36.5% (range -0.5% to -62.5%). 10 out of 17 (59%) patients were non-responders and 8 of these had a reduction in SUVmax with a mean percentage value of -36.2% (range 11.3% to -70.7).
Conclusions
Baseline SUVmax measurements of FLT PET-CT were significantly related to Ki-67 suggesting that it is a proliferation biomarker. However, in this series neither the baseline value or the change in SUVmax after one cycle of NAC were able to predict response as most patients had a sizeable SUVmax reduction.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P4-01-07.
Collapse
Affiliation(s)
- DK Woolf
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - M Beresford
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - SP Li
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - B Sanghera
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - WL Wong
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - V Amin
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - M-L Ah-See
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - D Miles
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - L Sonoda
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - S Detre
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - M Dowsett
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| | - A Makris
- Academic Oncology Unit, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal United Hospital Bath, Bath, United Kingdom; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom; Royal Marsden Hospital, London, United Kingdom
| |
Collapse
|
7
|
Montoro Lopez M, Iniesta Manjavacas A, De Torres Alba F, Lopez Fernandez T, De Celix MCGR, Gomez De Diego J, Ramirez U, Mesa J, Moreno Yanguela M, Lopez Sendon J, Shiina Y, Ernst S, Gatzoulis M, Li W, Cameli M, De Vito R, Di Giovanni A, Lisi M, Focardi M, Giacomin E, Bigio E, Mondillo S, Szymczyk E, Lipiec P, Michalski B, Szymczyk K, Rotkiewicz A, Wozniakowski B, Stefanczyk L, Kasprzak J, Luo X, Fang F, Lee AP, Lam Y, Sanderson JE, Kwong JS, Yu C, Nasis A, Moir S, Meredith I, Mottram P, Van Zalen J, Podd S, Raju P, Mcintosh R, Beale L, Brickley G, Sturridge L, Patel N, Lloyd G, Esteban Martinez F, Ariza Canete J, Casanova Martin M, Ciudad Caballero M, Trapiello Gonzalez L, Herrera Gutierrez N, Matei F, Beladan C, Popescu B, Calin A, Rosca M, Curea F, Calin C, Ginghina C, Baronaite-Dudoniene K, Vaskelyte JJ, Puodziukynas A, Smalinskas V, Urbonaite L, Botezatu CD, Enache R, Rosca M, Beladan CC, Calin A, Gurzun MM, Ginghina C, Popescu BA, Ercan S, Kervancioglu S, Davutoglu V, Cakici M, Ozkur A, Oylumlu M, Sari I, Faustino A, Paiva L, Providencia R, Trigo J, Botelho A, Costa M, Leitao-Marques A, Al Barjas M, Alwis L, Sonoda L, Balan K, Alqaseer M, Jelani A, Niaz K, Andres Lahuerta A, Igual Munoz B, Alonso Fernandez P, Maceira A, Cano O, Osca J, Sancho-Tello M, Jimenez Carreno R, De Munoz YR, De Ros JO, Bonanad Lozano C, Lopez-Lereu M, Monmeneu J, Estornell J, Igual Munoz B, Maceira A, Chaustre F, Sanchis J, Badr Eslam R, Pfaffenberger S, Marzluf B, Frey M, Bartko P, Babayev J, Kammerlander A, Maurer G, Mascherbauer J. Club 35 Poster session Friday 7 December: Dobutamine stress echo. Eur Heart J Cardiovasc Imaging 2012. [DOI: 10.1093/ehjci/jes262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
8
|
Abstract
BACKGROUND Anal cancer is a rare tumour accounting for ∼2% of all colorectal cancers between 1997 and 2000 in the UK. Staging is still dominated by DRE (digital rectal examination), computed tomography (CT) and magnetic resonance imaging (MRI) imaging. The role of PET as a definitive modality is still emerging and there are relatively few adequate studies in the literature. METHODS We looked at patients treated radically for anal cancer at Mount Vernon Cancer Centre (UK) between 2009 and 2010. Eighty-eight patients underwent treatment according to data-based coding records of which 46 had positron emission tomography (PET)/CT scans. Notes were unavailable for three patients. We compared staging following conventional modalities (DRE, MRI and CT) and PET/CT scans for these 43 patients. RESULTS In 18 patients, the PET/CT stage differed from MRI. PET/CT altered the stage in 42% of patients but changes in subsequent management were not implemented. CONCLUSIONS Our data show that PET/CT does alter staging in a significant number of cases although it did not lead to change in management under the current guidelines. Furthermore, there is agreement that PET/CT shows greater sensitivity for detection of lymph nodes and our study has demonstrated a distinct trend towards upstaging of anal cancer with PET/CT.
Collapse
Affiliation(s)
- N J Bhuva
- Department of Radiotherapy, Oncology Division, Mount Vernon Cancer Centre, Middlesex, UK.
| | - R Glynne-Jones
- Department of Radiotherapy, Oncology Division, Mount Vernon Cancer Centre, Middlesex, UK
| | - L Sonoda
- Department of Radiotherapy, Oncology Division, Mount Vernon Cancer Centre, Middlesex, UK
| | - W-L Wong
- Department of Radiotherapy, Oncology Division, Mount Vernon Cancer Centre, Middlesex, UK
| | - M K Harrison
- Department of Radiotherapy, Oncology Division, Mount Vernon Cancer Centre, Middlesex, UK
| |
Collapse
|
9
|
Matsuo K, Srivastava S, Tripathi P, Sonoda L, Yoo E, Pfaffenbac K, Dubeau L, Lee A, Lin Y. Adiposity and endometrial cancer: The stress of excess. Gynecol Oncol 2011. [DOI: 10.1016/j.ygyno.2010.12.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
10
|
Taylor K, Britton P, Sonoda L, Wallis M, Sinnatamby R. Is it safe practice not to biopsy fibroadenomas in women under 30? Breast Cancer Res 2009. [PMCID: PMC4284832 DOI: 10.1186/bcr2371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
11
|
Abstract
An increasing number of breast lesions are being detected incidentally on CT. The aim of this study was to investigate the rate of referrals to the breast unit for assessment of lesions identified on CT and the resulting yield of previously undiagnosed breast malignancies from this pathway. A retrospective review was undertaken of CT examinations conducted over a period of 14 years. All patients (with no previous history of breast cancer) whose report contained the keyword "breast" and who were referred to a specialist breast unit for assessment were reviewed. CT lesion morphology and enhancement pattern were identified and compared with the final diagnostic outcome. 70 patients were identified by retrospective analysis, yielding 78 incidental breast lesions, of which 22 (28.2%) were malignant (category B5). This gave a positive predictive value (PPV) for malignancy of 28.2%. The best morphological predictor of malignancy was spiculation (PPV, 76%) and irregularity (PPV, 58%), whereas calcification patterns (PPV, 36%) were diagnostically unhelpful. Malignant lesions were likely to be larger (mean, 28.5 mm) than benign lesions (mean, 20.2 mm; p<0.05). In conclusion, 30% of incidental breast lesions in this large series of patients proved to be unsuspected breast cancers, particularly irregular spiculated masses. Referral for formal triple assessment of CT-diagnosed breast lesions is worthwhile, and careful examination of the breast should be a routine part of CT examinations.
Collapse
Affiliation(s)
- P Moyle
- Cambridge Breast Unit, Department of Radiology, Cambridge University Hospital NHS Trust, Hills Road, Cambridge CB2 2QQ, UK.
| | | | | | | |
Collapse
|
12
|
Miller VM, Kim J, Zou F, Levites Y, Jansen-West K, Zwizinski CW, Moore BD, Troendle FJ, Bann M, Verbeeck C, Price R, Smithson L, Rangachari V, Sonoda L, Wagg K, Ma L, Cangemi D, Younkin SG, Pankratz VS, Petersen RC, Dickson D, Rosenberry T, Younkin SG, Golde TE. P2‐347: BRI2 (ITM2B) inhibits Aβ deposition. Alzheimers Dement 2008. [DOI: 10.1016/j.jalz.2008.05.1424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Li Ma
- Mayo ClinicJacksonvilleFLUSA
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Movie P, Sonoda L, Britton P, Sinnatamby R. Incidental breast lesions found on computer tomography – what is their significance? European Journal of Cancer Supplements 2008. [DOI: 10.1016/s1359-6349(08)70353-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
14
|
Rocha MDS, Costa NS, Costa JC, Angelo MT, Lessa Angelo Júnior JR, Sonoda L, de Andrade MR, Scatigno Neto A. CT identification of ascaris in the biliary tract. Abdom Imaging 1995; 20:317-9. [PMID: 7549734 DOI: 10.1007/bf00203362] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Ascariasis is one of the most common helminthic diseases worldwide. The presence of this worm in the biliary tree causes biliary colic, recurrent pyogenic cholangitis, pancreatitis, hepatic abscesses, and septicemia. The diagnosis of biliary ascariasis is usually made by ultrasound (US). We report the computerized-tomography (CT) aspects that allowed the identification of ascaris in the biliary tract in two patients.
Collapse
Affiliation(s)
- M de S Rocha
- Faculdade de Medicina, Universidade de São Paulo, Brazil
| | | | | | | | | | | | | | | |
Collapse
|